These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28723806)

  • 21. Pepsinogen test for the evaluation of precancerous changes in gastric mucosa: a population-based study.
    Sjomina O; Pavlova J; Daugule I; Janovic P; Kikuste I; Vanags A; Tolmanis I; Rudzite D; Polaka I; Kojalo I; Liepniece-Karele I; Isajevs S; Santare D; Pirags V; Pahomova J; Dzerve V; Tzivian L; Erglis A; Leja M
    J Gastrointestin Liver Dis; 2018 Mar; 27(1):11-17. PubMed ID: 29557410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum Pepsinogen as a Predictor for Gastric Cancer Death: A 16-Year Community-based Cohort Study.
    Chiang TH; Chiu SY; Chen SL; Yen AM; Fann JC; Liu CY; Chou CK; Chiu HM; Shun CT; Wu MS; Lin JT; Lee YC; Chen TH; Lin MW
    J Clin Gastroenterol; 2019; 53(5):e186-e193. PubMed ID: 29369241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric cancer screening using the serum pepsinogen test method.
    Miki K
    Gastric Cancer; 2006; 9(4):245-53. PubMed ID: 17235625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer.
    Wang Y; Zhu Z; Liu Z; Zhao Z; Xue X; Li X; Li P; Rong G; Ma Y
    J Int Med Res; 2020 Mar; 48(3):300060520914826. PubMed ID: 32228342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection.
    Kwon Y; Jeon S; Nam S; Shin I
    Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of serum pepsinogen I , II and osteopontin co-detection in gastric cancer screening].
    Gong YH; Sun LP; Yuan Y
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):691-3. PubMed ID: 17274377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Method evaluation of pepsinogen I/II assay based on chemiluminescent immunoassays and comparison with other test methods.
    Cho EJ; Kim HK; Jeong TD; Ko DH; Bae SE; Lee JS; Lee W; Choe JW; Chun S; Jung HY; Min WK
    Clin Chim Acta; 2016 Jan; 452():149-54. PubMed ID: 26585753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Serum Pepsinogen I and II Ratio in Screening of Gastric Carcinoma.
    Begum A; Baten MA; Begum Z; Ahsan MM; Rahman SF; Chowdhury F; Khan AH
    Mymensingh Med J; 2017 Jul; 26(3):628-634. PubMed ID: 28919620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastric carcinoma].
    Li YH; Zhang XH; Huang B; Wang JL; Mi JM; Shen HT; Zhang ZG; Yan X; Xing LX; Wang SJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Oct; 27(10):840-4. PubMed ID: 17343174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.
    Lee JY; Park KS; Lee HG; Baek WK; Cho KB; Lee YJ; Lee YS; Ryu SW
    Clin Exp Med; 2017 Aug; 17(3):403-410. PubMed ID: 27154568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
    Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
    Kishikawa H; Kimura K; Ito A; Arahata K; Takarabe S; Kaida S; Miyauchi J; Miura S; Kanai T; Nishida J
    Digestion; 2017; 95(3):229-236. PubMed ID: 28355604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of MRI-DWI signal intensity value combined with serum PGI, PGII and CA199 in early gastric cancer.
    Li M; Zheng G; Yu L; Tan LL; Li X; Li MJ; Li C; Li S; Liang J; Zhong Z; Li ZM
    Cell Mol Biol (Noisy-le-grand); 2021 Aug; 67(2):95-100. PubMed ID: 34817333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels.
    Yanaoka K; Oka M; Yoshimura N; Mukoubayashi C; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Yamamichi N; Fujishiro M; Takeshita T; Mohara O; Ichinose M
    Int J Cancer; 2008 Aug; 123(4):917-26. PubMed ID: 18508314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pepsinogen I and pepsinogen II, PG I/II ratio].
    Miki K; Sasajima M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():778-81. PubMed ID: 20960872
    [No Abstract]   [Full Text] [Related]  

  • 37. [The relationship between concentrations of pepsinogens in blood serum and pathohystologic parameters of stomach adenomas and adenocarcinomas].
    Sosnina AV; Sorokina NN; Autenshlius AI; Morozov DV; Isakova NB; Vankhal'skiĭ AV; Fursov SA
    Klin Lab Diagn; 2013 Feb; (2):21-3. PubMed ID: 23808005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum pepsinogen I/II ratio test].
    Miki K
    Nihon Rinsho; 2003 Jan; 61(1):92-5. PubMed ID: 12607323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcome of group D patients with negative serum anti-Helicobacter pylori antibody and positive serum pepsinogen test in healthy Koreans.
    Han YM; Chung SJ; Choi JM; Lee C; Kim JS
    J Dig Dis; 2018 Sep; 19(9):529-539. PubMed ID: 30117281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.